An immunohistochemical study of interleukin-8 (IL-8) in breast cancer

Acta Histochemica

Volumn 114, Issue 6, 2012, Pages 571-576

  Zuccari, Debora Aparecida Pires de Campos ^a   Leonel, Camila ^b   Castro, Rodrigo ^a   Gelaleti, Gabriela Bottaro ^b   Jardim, Bruna Victorasso ^b   Moscheta, Marina Gobbe ^a   Regiani, Vitor Rafael ^a   Ferreira, Lívia Carvalho ^a   Lopes, Juliana Ramos ^b   Neto, Dalisio de Santi ^a   Esteves, José Luis ^a  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Breast cancer; Immunohistochemistry; Interleukin 8; Prognostics; Women

Indexed keywords

CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; INTERLEUKIN 8; KI 67 ANTIGEN; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL PRACTICE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENT CANCER; TUMOR MICROENVIRONMENT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84861662822     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2011.10.007     Document Type: Article

References (31)

1. Ahmed O.I., Adel A.M., Diab D.R., Gobran N.S. Prognostic value of serum level of interleukin-6 and interleukin-8 in metastatic breast cancer patients. Egypt J Immunol 2006, 13:61-68.
2. Bendrik C., Dabrosin C. Estradiol increases IL-8 secretion of normal human breast tissue and breast cancer in vivo. J Immunol 2009, 182:371-378.
3. Bobrovnikova-Marjon E.V., Marjon P.L., Barbash O., Vander Jagt D.L., Abcouwer S.F. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1. Cancer Res 2004, 64:4858-4869.
4. Chen Y., Chen L., Li J.Y., Mukaida N., Wang Q., Yang C., et al. ERβ and PEA3 co-activate IL-8 expression and promote the invasion of breast cancer cells. Cancer Biol Ther 2011, 11:497-511.
5. De Larco J.E., Wuertz B.R., Yee D., Rickert B.L., Furcht L.T. Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells. Proc Natl Acad Sci U S A 2003, 24:13988-13993.
6. Derin D., Soydinc H.O., Guney N., Tas F., Camlica H., Duranvildiz D., et al. Serum IL-8 and IL-12 levels in breast cancer. Med Oncol 2007, 24:163-168.
7. Fuksiewicz M., Kaminska J., Kotowicz B., Kowalska M., Rubach M., Pienkowsi T. Serum cytokine levels and the expression of estrogen and progesterone receptors in breast cancer patients. Clin Chem Lab Med 2006, 44:1092-1097.
8. Gonzalez-ângulo A.M., Moraes-Vasquez F., Hortobagyl G.N. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007, 608:1-22.
9. Instituto Nacional do Câncer (INCA) Estimativas da incidência e mortalidade por câncer no Brasil 2010, Ministério da Saúde, Rio de Janeiro, Available at http://www.inca.gov.br/estimativa/2010/index.asp?link=conteudo_view.asp&ID=5 [accessed 20.11.10].
10. Ju D., Sun D., Xiu L., Meng X., Zhang C., Wei P. Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells. Med Oncol 2010, 10.1007/s12032-010-9780-0.
11. Kido S., Kitadai Y., Hattori N., Haruma K., Kido T., Ohta M. Interleukin 8 and vascular endothelial growth factor-prognostic factors in human gastric carcinomas?. Eur J Cancer 2001, 37:1482-1487.
12. Lai Y., Shen Y., Liu X., Zhang Y., Zeng Y., Liu Y. Interleukin-8 induces the endothelial cell migration through the activation of phosphoinositide 3-Kinase-Rac1/RhoA pathway. Int J Biol Sci 2011, 7:782-791.
13. Lazennec G., Ali S. Chemokines: novel targets for breast cancer metastasis. Cancer Metastasis 2007, 26:401-420.
14. Lee L.F., Hellendall R.P., Wang Y., Haskill J.S., Mukaida N., Matsushima K. IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration. J Immunol 2000, 164:2769-2775.
15. Leek R.D., Harris A.L., Lewis C.E. Cytokine networks in solid human tumours: regulation of angiogenesis. J Leukoc Biol 1994, 42:423-435.
16. Li A., Bostick-bruton F., Reed E. Effects of interleukin-1α and tumour necrosis factor-α on cisplatin-induced ERCC-1 mRNA expression in human ovarian carcinoma cell line. Anticancer Res 1998, 18:2283-2288.
17. Lin Y., Wang S.M., Lu W.M., Huang R.P. Effect of interleukin-8 in cell invasion and proliferation of human breast cancer. Zhonghua Wai Ke Za Zhi 2005, 43:1541-1544.
18. Ning Y., Manegold P.C., Hong Y.K., Zhang W., Pohl A., Lurie G., et al. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer 2010, 128:2038-2049.
19. Nutz S., Doll K., Karlovsky P. Determination of the LOQ in real-time PCR by receiver operating characteristic curve analysis: application to qPCR assays for Fusarium verticillioides and F. proliferatum. Anal Bioanal Chem 2011, 2:717-726.
20. Oladipo O., Conlon S., O'Grady A., Purcell C., Wilson C., Maxwell P.J., et al. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue. Br J Cancer 2011, 104:480-487.
21. Pedersen L., Gunnarsdottir ka, Rasmussen B.B., Moeller S., Lanng C. The prognostic influence of multifocality in breast cancer patients. Breast 2004, 13:188-193.
22. Rakha E.A., Reis-Filho J.S., Baehner F., Dabbs D.J., Decker T., Eusebi V., et al. Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 2010, 12:1-12.
23. Simeone A.M., Nieves-Alicea R., McMurtry V.C., Colella S., Krahe R., Tari A.M. Cyclooxygenase-2 uses the protein kinase C/interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells. Int J Oncol 2007, 30:785-792.
24. Snoussi K., Mahfoudh W., Bouaouina N., Ahmed S.B., Helal A.N., Chouchane L. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast cancer. Hum Immunol 2006, 67:13-21.
25. Van't Veer L.J., Paik S., Hayes D.F. Gene expression profiling of breast cancer: a new tumor marker. J Clin Oncol 2005, 23:1631-1635.
26. Vazquez-martin A., Colomer R., Menedez J.A. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer. Eur J Cancer 2007, 43:1117-1124.
27. Waugh D.J., Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008, 14:6735-6741.
28. Yao C., Wang S.M., Xie D., Wu H.X., Chen D.Y., Lin Y. The relationship between expression of interleukin-8 and prognosis of breast cancer. Zhonghua Wai Ke Za Zhi 2006, 44:900-903.
29. Yao C., Lin Y., Ye C.S., Bi J., Zhu Y.F., Wang S.M. Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer. Chin Med J 2007, 120:1766-1772.
30. Yoshimura T., Matsushima K., Oppenheim J.J., Leonard E.J. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 IL 1. J Immunol 1987, 139:788-793.
31. Zhous S., Wang Guo-Ping, Liu C., Zhou M. Eukaryotic iniciation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer. BMC Cancer 2006, 6:1471-2407.